Jeppe Thorlacius-Ussing

10PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer cell biologySolid tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2024
Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis.

Rasmus S Pedersen, Jeppe Thorlacius-Ussing, Maria G Raimondo

|Sep 20, 2023
The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes.

Jeppe Thorlacius-Ussing, Christina Jensen, Neel I Nissen

|Aug 19, 2023
Preliminary investigation of elevated collagen and blood-clotting markers as potential noninvasive biomarkers for small cell lung cancer.

Jeppe Thorlacius-Ussing, Søren Risom Kristensen, Morten Asser Karsdal

|Apr 28, 2023
Autoreactivity against Denatured Type III Collagen Is Significantly Decreased in Serum from Patients with Cancer Compared to Healthy Controls.

Christina Jensen, Patryk Drobinski, Jeppe Thorlacius-Ussing

|Dec 11, 2022
Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer.

Emilie A Madsen, Jeppe Thorlacius-Ussing, Neel I Nissen

|Sep 23, 2022
Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.

Rasmus S Pedersen, Neel I Nissen, Christina Jensen

Pageof 2

Frequent Collaborators

4 joint publications

Christina Jensen

3 joint publications

Neel I Nissen

3 joint publications

Inna M Chen

3 joint publications

Lars N Jørgensen